{"id":106369,"date":"2021-02-05T22:31:42","date_gmt":"2021-02-05T22:31:42","guid":{"rendered":"https:\/\/fin2me.com\/?p=106369"},"modified":"2021-02-05T22:31:42","modified_gmt":"2021-02-05T22:31:42","slug":"brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/","title":{"rendered":"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week"},"content":{"rendered":"
FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS\/Tatyana Makeyeva<\/figcaption>

BRASILIA (Reuters) – Brazilian drug maker Uni\u00e3o Qu\u00edmica expects to have regulatory approval and a government contract by next week for Russia\u2019s Sputnik V vaccine against COVID-19, its director for international business Rogerio Rosso told Reuters on Friday.<\/p>\n

Rosso said the company expects to draw up a contract by Wednesday with the health ministry for an initial 10 million ready-for-use imported doses based on a reference price of $10 per dose.<\/p>\n

He said the ministry is also interested in buying the firm\u2019s entire domestic production of Sputnik V, an estimated 8 million doses a month from April, for Brazil\u2019s national immunization program.<\/p>\n

Rosso added he expects Brazilian health regulator Anvisa will approve emergency use of the Russian vaccine next week, as the agency eased requirements for such an authorization.<\/p>\n

The first of 10 million doses committed by Russia are ready for dispatch to Brazil as soon as Anvisa greenlights the shot.<\/p>\n

Neither the health ministry nor Anvisa immediately replied to a request for comment.<\/p>\n

With approval by Lebanon on Friday, Sputnik V has been authorized for emergency use in 18 countries besides Russia, said the Russian Direct Investment Fund (RDIF), which is marketing the vaccine. The two-dose vaccine has an efficacy of 91.6%, according to data published on Tuesday in The Lancet medical journal.<\/p>\n

RDIF chief executive Kirill Dmitriev has said Brazil could become a Sputnik V supplier to its neighbors in Latin America, where six nations have approved the vaccine, including Argentina, which started immunizations with it in December.<\/p>\n

Rosso, a former congressman and governor of Brasilia, said that will have to wait now that the Brazilian government plans to buy Uni\u00e3o Qu\u00edmica\u2019s output, at least until the company can ramp up production later this year with additional equipment.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS\/Tatyana MakeyevaBRASILIA (Reuters) – […]<\/p>\n","protected":false},"author":3,"featured_media":106368,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nBrazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me\" \/>\n<meta property=\"og:description\" content=\"FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS\/Tatyana MakeyevaBRASILIA (Reuters) – [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-05T22:31:42+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cnewsfotor615.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/\",\"url\":\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/\",\"name\":\"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-02-05T22:31:42+00:00\",\"dateModified\":\"2021-02-05T22:31:42+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/","og_locale":"en_US","og_type":"article","og_title":"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me","og_description":"FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS\/Tatyana MakeyevaBRASILIA (Reuters) – [...]","og_url":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/","og_site_name":"Fin2me","article_published_time":"2021-02-05T22:31:42+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/02\/cnewsfotor615.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/","url":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/","name":"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-02-05T22:31:42+00:00","dateModified":"2021-02-05T22:31:42+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/brazil-drugmaker-seeks-contract-regulatory-ok-for-russian-vaccine-next-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"Brazil drugmaker seeks contract, regulatory OK for Russian vaccine next week"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/106369"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=106369"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/106369\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/106368"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=106369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=106369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=106369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}